The growth of the metastatic colorectal cancer market is driven by a rising demand for faster diagnosis and treatment of metastatic colorectal cancer in individuals, especially the elderly, coupled with the advancement in medical technology that promotes innovative and efficient methods like image guided therapy and targeted therapy. However, the complexities associated with the diagnosis of metastatic colorectal cancer globally, coupled with the regulations in the global metastatic colorectal cancer market can impede the growth of the market in the coming years.
The COVID-19 pandemic has adversely affected the lives of individuals as well as businesses around the globe. The access to healthcare for general health purposes has seen a fall in the last 24 months due to the rapid spread of the coronavirus. Despite the rolling out of the COVID-19 vaccines in numerous countries, the total number of cases are rising globally, and the virus is mutating which is of huge concern for medical professionals. However, government bodies are largely focussing on the detection of various types of cancers in individuals, as the victims of cancer can have additional complications if contacted by the coronavirus infection. Investments towards the treatment of colorectal cancer is seeing a growth, especially from private entities.
View Full Report Link:https://www.absolutemarketsinsights.com/reports/Global-Metastatic-Colorectal-Cancer-Market-2022---2029-1038
The key players operating in the global metastatic colorectal cancer market:
- Amgen Inc.
- Arcus Biosciences, Inc.
- Array BioPharma Inc
- CARDIFF ONCOLOGY
- Celyad Oncology SA
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd
- Elevar Therapeutics
- F. Hoffmann-La Roche Ltd.
- G1 Therapeutics, Inc.
- Genentech USA, Inc.
- Immunovative Therapies, Ltd.
- Merck KGaA
- Mirati Therapeutics, Inc.
- Novartis AG
- Scandion Oncology A/S
- Shanghai Henlius Biotech, Inc.
- Sumitomo Dainippon Pharma Co., Ltd.
- Suzhou Zelgen Biopharmaceuticals Co., Ltd.
- Symphogen
- The Menarini Group
- Treos Bio Limited
- Other Market Participants
Global Metastatic Colorectal Cancer Market Segmentation
The global metastatic colorectal cancer market has been segmented on the basis of metastasizing site, treatment type, application, end-users, which are further classified into regions and its respective countries:
Global Metastatic Colorectal Cancer Market Metastasizing Site Outlook (Revenue, USD Million, 2015 - 2029)
- Lungs
- Liver
- Brain
- Lymph Nodes
- Others
Global Metastatic Colorectal Cancer Market Treatment Type Outlook (Revenue, USD Million, 2015 - 2029)
- Surgery
- Radiation Therapy
- Chemo Therapy
- Targeted Therapy and Immunotherapy
- Image Guided Therapy
- Others
Global Metastatic Colorectal Cancer Market Application Outlook (Revenue, USD Million, 2015 - 2029)
- Kids
- Adults
Global Metastatic Colorectal Cancer Market End-User Outlook (Revenue, USD Million, 2015 - 2029)
- Healthcare Facilities
- Specialized Cancer Centers
- Research Centers
- Others
Global Metastatic Colorectal Cancer Market Metastatic Colorectal Cancer Regional Outlook (Revenue, USD Million, 2015 - 2029)
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +917400242424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/
No comments:
Post a Comment